HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acceleration of kidney function decline after incident hospitalization with cardiovascular disease: the Stockholm CREAtinine Measurements (SCREAM) project.

AbstractAIMS:
The cardiorenal syndrome refers to a bidirectional relationship between the kidney and the heart. However, epidemiological evidence of cardiovascular disease (CVD) as a risk factor for chronic kidney disease (CKD) progression is actually scarce.
METHODS AND RESULTS:
We examined the slopes of estimated glomerular filtration rate (eGFR) decline in the 2 years before vs. after an incident hospitalization with heart failure (HF) (n = 20 420), coronary heart disease (CHD) (n = 18 152), or stroke (n = 1808) using data from a complete laboratory data collection in Stockholm, Sweden between 2006 and 2011. eGFR slopes were estimated using mixed-effect models with unstructured residual correlation. Overall, incident hospitalization with HF and CHD, but not stroke, was significantly associated with a subsequent accelerated decline in eGFR, with a faster eGFR decline and greater slope change after HF than CHD. The pre-event vs. post-event eGFR slopes (mL/min/1.73 m2 per year) were -1.67 (-1.77 to -1.57) vs. -2.76 (-2.82 to -2.71), with a Δslope of -1.09 (-1.16 to -1.02) for HF; -1.09 (-1.20 to -0.98) vs. -1.87 (-1.92 to -1.81), with a Δslope of -0.78 (-0.85 to -0.70) for CHD; and -1.00 (-1.37 to -0.63) vs. -0.99 (-1.19 to -0.78), with a Δslope of 0.02 (-0.24 to 0.27) for stroke. The accelerated declines in eGFR after HF and CHD were consistent across the spectrum of eGFR, although pre-event eGFR slopes were steeper in lower eGFR (e.g. pre-event eGFR slope for HF -0.64 (-0.76 to -0.53) for eGFR ≥60 mL/min/1.73 m2 , -1.43 (-1.57 to -1.30) for eGFR 30-59 mL/min/1.73 m2 , and -2.42 (-2.71 to -2.12) for eGFR <30 mL/min/1.73 m2 ).
CONCLUSIONS:
Incident hospitalization with cardiac diseases (i.e. HF and CHD) was significantly associated with a subsequent acceleration of eGFR decline.
AuthorsJunichi Ishigami, Marco Trevisan, Lars H Lund, Tomas Jernberg, Josef Coresh, Kunihiro Matsushita, Juan-Jesus Carrero
JournalEuropean journal of heart failure (Eur J Heart Fail) Vol. 22 Issue 10 Pg. 1790-1799 (10 2020) ISSN: 1879-0844 [Electronic] England
PMID32683762 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 European Society of Cardiology.
Chemical References
  • Creatinine
Topics
  • Acceleration
  • Cardiovascular Diseases (epidemiology)
  • Creatinine
  • Glomerular Filtration Rate
  • Heart Failure (epidemiology)
  • Hospitalization
  • Humans
  • Kidney
  • Renal Insufficiency, Chronic (epidemiology)
  • Risk Factors
  • Sweden (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: